| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52c18b056a96cd2aa52c00ead8603a96 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44a6ef4810987e149c05a6c6de76dd49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d096a7b91abc0da2eb249f9a898fbb4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_950f5a1278cc0a2e6f00754fb465d815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25361cdcbc0ec5e61e6b6eee02394284 |
| publicationDate |
2023-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2023014962-A1 |
| titleOfInvention |
Quinoline compound and use thereof |
| abstract |
Disclosed are a class of quinoline compounds and use thereof. This class of compounds has good inhibitory activity to a fibroblast growth factor receptor 4 (FGFR4), may be used as a receptor tyrosine kinase inhibitor, in particular as an FGFR4 kinase irreversible inhibitor, and is used for preparing drugs for preventing and/or treating FGFR4 overexpression-mediated diseases in organisms and diseases associated with angiogenesis or cancer metastasis. |
| priorityDate |
2019-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |